Preferred Label : fesoterodine;

MeSH note : a muscarinic antagonist for treatment of overactive bladder;

CISMeF synonym : toviaz;

MeSH Related Number : 286930-03-8 (fesoterodine); fesoterodine fumarate; EOS72165S7;

Registry Number MeSH : 286930-03-8;

Related CAS MeSH : EOS72165S7 (fesoterodine fumarate);

Is substance : O;

UNII : 621G617227;

InChIKey : DCCSDBARQIPTGU-HSZRJFAPSA-N;

Details


Main resources

You can consult :


http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=68479557
2014
false
false
false
France
French
summary of product characteristics
package leaflet
released
long
fesoterodine fumarate
TOVIAZ
pill, nos
tablets
compression, nos
fesoterodine fumarate
fesoterodine
fumarates
benzhydryl compounds

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=66259498
2014
false
false
false
France
French
summary of product characteristics
package leaflet
fesoterodine fumarate
fesoterodine
TOVIAZ
long
released
fesoterodine fumarate
compression, nos
fumarates
pill, nos
tablets
benzhydryl compounds

---
http://www.has-sante.fr/portail/jcms/c_1225086/toviaz
http://www.has-sante.fr/portail/jcms/c_1622329/fr/toviaz
http://www.has-sante.fr/portail/jcms/c_1622328/fr/toviaz-26062013-avis-ct12712
2013
false
France
French
evaluation of the transparency committee
guidelines for drug use
benzhydryl compounds
benzhydryl compounds
fesoterodine
administration, oral
Delayed-Action preparations
fesoterodine fumarate
fesoterodine
insurance, health, reimbursement
urinary incontinence
urinary bladder, overactive
adult
aged
treatment outcome
muscarinic antagonists
muscarinic antagonists
fesoterodine
fesoterodine fumarate
clinical trials, phase iii as topic
randomized controlled trials as topic
meta-analysis as topic
risk management
TOVIAZ
Fesoterodine 4mg m/r tablet (product)
Fesoterodine 8mg m/r tablet (product)

---
http://www.has-sante.fr/portail/jcms/c_1250204/toviaz-fesoterodine-anticholinergique
2012
false
France
French
guidelines for drug use
evaluation of the transparency committee
benzhydryl compounds
benzhydryl compounds
administration, oral
Delayed-Action preparations
fesoterodine
fesoterodine
fesoterodine fumarate
fesoterodine fumarate
fesoterodine
insurance, health, reimbursement
urinary bladder, overactive
adult
aged
cholinergic antagonists
cholinergic antagonists
treatment outcome
meta-analysis as topic
randomized controlled trials as topic
TOVIAZ

---
https://www.ema.europa.eu/medicines/human/EPAR/Toviaz
2012
false
United Kingdom
English
French
syndication feed
benzhydryl compounds
benzhydryl compounds
TOVIAZ
cholinergic antagonists
urinary incontinence
urinary incontinence, urge
treatment outcome
drug evaluation
urinary bladder, overactive
fesoterodine
fesoterodine
fesoterodine fumarate
fesoterodine fumarate
fesoterodine
drug evaluation
package leaflet
summary of product characteristics

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.